An In Vitro‐In Vivo Comparative Study Using Highly Sensitive Radioisotopic Assays to Assess the Predictive Power of Emerging Blood‐Brain Barrier Models
Small Methods · 2025
DOI: 10.1002/smtd.202401400 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Small Methods, 2025. Verfasst von Ahmed Refaat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Melbourne, V…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Radioisotopes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Microfluidic BBB‐on‐a‐chip models (μBBB) aim to recapitulate the organotypic features of the human BBB with great potential to model CNS diseases and advance CNS therapeutics. Nevertheless, their predictive capacity for drug uptake into the brain remains uncertain due to limited evaluation with only a small number of model drugs. Here, the in vivo brain uptake of a panel of nine radiolabeled compounds is evaluated in Swiss‐outbred mice following a single intravenously administered dose and compared against results from the microfluidic μBBB platform and the conventional Transwell BBB model. Radioisotopic measurements are employed to calculate brain‐to‐plasma concentration ratios (B/P) of the compounds both in vivo and in vitro. The in vitro‐in vivo correlation plots of the B/P ratios revealed a strong positive correlation (r = 0.8081, R 2 = 0.6530) for the μBBB, suggesting a high degree of predictive ability for drug permeability into the brain. In contrast, the Transwell assay showed a weaker in vitro‐in vivo correlation (r = 0.6467, R 2 = 0.4182). Finally, brain uptake of radiolabeled, brain‐targeted, angiopep2‐conjugated nanoparticles (ANG2‐NP) is assessed in the μBBB and results mirrored the in vivo uptake, while the Transwell model failed to resolve the differences between the targeted and non‐targeted NPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Melbourne, VIC, 3052, Australia.
- Department of Defence, Defence Science and Technology Group, 506 Lorimer Street, Port Melbourne, VIC, 3207, Australia.
- Commonwealth Scientific and Industrial Research Organization, Research Way, Melbourne, VIC, 3168, Australia.
- Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, 151 Wellington Rd, Melbourne, VIC, 3168, Australia.
- Department of Materials Science & Engineering, Faculty of Engineering, Monash University, 14 Alliance Ln, Melbourne, VIC, 3168, Australia.
ORCID-Profile: Ahmed Refaat, Patrick Thomas, Lars Esser, Ziqiu Tong, Joseph A Nicolazzo, Nicolas H Voelcker
Zitieren
APA
Refaat, A., Thomas, P., Zhang, W., Esser, L., Tong, Z., Beer, M., Mawdsley, D., Thirkettle-Watts, D., Shields, K. A., Nicolazzo, J. A., & Voelcker, N. H. (2025). An In Vitro‐In Vivo Comparative Study Using Highly Sensitive Radioisotopic Assays to Assess the Predictive Power of Emerging Blood‐Brain Barrier Models. Small Methods. https://doi.org/10.1002/smtd.202401400
Vancouver
Refaat A, Thomas P, Zhang W, Esser L, Tong Z, Beer M, et al. An In Vitro‐In Vivo Comparative Study Using Highly Sensitive Radioisotopic Assays to Assess the Predictive Power of Emerging Blood‐Brain Barrier Models. Small Methods. 2025. doi:10.1002/smtd.202401400
BibTeX
@article{Refaat2025,
author = {Refaat, Ahmed and Thomas, Patrick and Zhang, Weisen and Esser, Lars and Tong, Ziqiu and Beer, Michael and Mawdsley, David and Thirkettle-Watts, David and Shields, Katherine A and Nicolazzo, Joseph A and Voelcker, Nicolas H},
title = {An In Vitro‐In Vivo Comparative Study Using Highly Sensitive Radioisotopic Assays to Assess the Predictive Power of Emerging Blood‐Brain Barrier Models},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202401400}
}
EUVIMED